Pacific Bioscience’s VP of Intellectual Property, Robert Reamey, claims questionable public SEC document “confidential corporate document”, but may “answer questions” in “over the telephone” negotiations.

Pacific Biosciences VP, Intellectual Property, Robert.H.Reamey, on behalf of Pacific Biosciences, claims that public SEC document Exhibit 10.7, dated June 15th 2010, is “a confidential corporate document” and cannot be released.

Read More